Lupin’s Goa facility may face regulatory action, says USFDA

"The USFDA has stated that this facility may be subject to regulatory or administrative action and that it may withhold approval of any pending applications or supplements in which this facility is listed," it added.

Original source: https://health.economictimes.indiatimes.com/news/pharma/lupins-goa-facility-may-face-regulatory-action-says-usfda/69588435?utm_source=RSS&utm_medium=ETRSS

Related Posts